sodium nitroprusside in 0.9% sodium chloride

Generic: sodium nitroprusside in 0.9% sodium chloride

Labeler: slate run pharmaceuticals, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name sodium nitroprusside in 0.9% sodium chloride
Generic Name sodium nitroprusside in 0.9% sodium chloride
Labeler slate run pharmaceuticals, llc
Dosage Form INJECTION
Routes
INTRAVENOUS
Active Ingredients

sodium nitroprusside .2 mg/mL

Manufacturer
Slate Run Pharmaceuticals, LLC

Identifiers & Regulatory

Product NDC 70436-205
Product ID 70436-205_09c94d69-7bea-2491-e063-6394a90a6438
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA215846
Listing Expiration 2026-12-31
Marketing Start 2022-12-31

Pharmacologic Class

Classes
vasodilation [pe] vasodilator [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 70436205
Hyphenated Format 70436-205

Supplemental Identifiers

RxCUI
1876368 1999185 2052423
UPC
0370436206803
UNII
EAO03PE1TC

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name sodium nitroprusside in 0.9% sodium chloride (source: ndc)
Generic Name sodium nitroprusside in 0.9% sodium chloride (source: ndc)
Application Number ANDA215846 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • .2 mg/mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-DOSE in 1 CARTON (70436-205-80) / 50 mL in 1 VIAL, SINGLE-DOSE
source: ndc

Packages (1)

70436-205-80 1 VIAL, SINGLE-DOSE in 1 CARTON (70436-205-80) / 50 mL in 1 VIAL, SINGLE-DOSE

Ingredients (1)

sodium nitroprusside (.2 mg/mL)

Linked Drug Pages (1)

sodium nitroprusside in 0.9% sodium chloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "09c94d69-7bea-2491-e063-6394a90a6438", "openfda": {"upc": ["0370436206803"], "unii": ["EAO03PE1TC"], "rxcui": ["1876368", "1999185", "2052423"], "spl_set_id": ["6f02e4ac-5f7c-4003-b9b7-283f489cddb0"], "manufacturer_name": ["Slate Run Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (70436-205-80)  / 50 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "70436-205-80", "marketing_start_date": "20221231"}], "brand_name": "sodium nitroprusside in 0.9% sodium chloride", "product_id": "70436-205_09c94d69-7bea-2491-e063-6394a90a6438", "dosage_form": "INJECTION", "pharm_class": ["Vasodilation [PE]", "Vasodilator [EPC]"], "product_ndc": "70436-205", "generic_name": "sodium nitroprusside in 0.9% sodium chloride", "labeler_name": "Slate Run Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "sodium nitroprusside in 0.9% sodium chloride", "active_ingredients": [{"name": "SODIUM NITROPRUSSIDE", "strength": ".2 mg/mL"}], "application_number": "ANDA215846", "marketing_category": "ANDA", "marketing_start_date": "20221231", "listing_expiration_date": "20261231"}